Key result
Co-overexpression of CSQ and TRN in mice normalized SR Ca2+ release compared with CSQ overexpression alone, but resulted in reduced survival, increased cardiac fibrosis, and depressed contractility.
The triadin-to-calsequestrin ratio is a critical modulator of SR Ca2+ signaling, where co-overexpression normalizes Ca2+ release but paradoxically worsens survival and contractile function due to fibrosis and blunted beta-adrenergic response.
Answers are grounded in this paper and cite their sources.
May caution against co-modulating SR proteins despite normalized Ca2+ release; leaves open triadin-calsequestrin ratio as therapeutic target in human cardiomyopathy.
Calsequestrin (CSQ) is a Ca(2+) storage protein that interacts with triadin (TRN), the ryanodine receptor (RyR), and junctin (JUN) to form a macromolecular tetrameric Ca(2+) signaling complex in the cardiac junctional sarcoplasmic reticulum (SR). Heart-specific overexpression of CSQ in transgenic mice (TG(CSQ)) was associated with heart failure, attenuation of SR Ca(2+) release, and downregulation of associated junctional SR proteins, e.g., TRN. Hence, we tested whether co-overexpression of CSQ and TRN in mouse hearts (TG(CxT)) could be beneficial for impaired intracellular Ca(2+) signaling and contractile function. Indeed, the depressed intracellular Ca(2+) concentration ([Ca](i)) peak amplitude in TG(CSQ) was normalized by co-overexpression in TG(CxT) myocytes. This effect was associated with changes in the expression of cardiac Ca(2+) regulatory proteins. For example, the protein level of the L-type Ca(2+) channel Ca(v)1.2 was higher in TG(CxT) compared with TG(CSQ). Sarco(endo)plasmic reticulum Ca(2+)-ATPase 2a (SERCA2a) expression was reduced in TG(CxT) compared with TG(CSQ), whereas JUN expression and [(3)H]ryanodine binding were lower in both TG(CxT) and TG(CSQ) compared with wild-type hearts. As a result of these expressional changes, the SR Ca(2+) load was higher in both TG(CxT) and TG(CSQ) myocytes. In contrast to the improved cellular Ca(2+), transient co-overexpression of CSQ and TRN resulted in a reduced survival rate, an increased cardiac fibrosis, and a decreased basal contractility in catheterized mice, working heart preparations, and isolated myocytes. Echocardiographic and hemodynamic measurements revealed a depressed cardiac performance after isoproterenol application in TG(CxT) compared with TG(CSQ). Our results suggest that co-overexpression of CSQ and TRN led to a normalization of the SR Ca(2+) release compared with TG(CSQ) mice but a depressed contractile function and survival rate probably due to cardiac fibrosis, a lower SERCA2a expression, and a blunted response to β-adrenergic stimulation. Thus the TRN-to-CSQ ratio is a critical modulator of the SR Ca(2+) signaling.
No takes yet. Share an insight, caveat, or question.
Kučerová et al. (2012) studied Impaired intracellular Ca2+ signaling and contractile function. Co-overexpression of CSQ and TRN (TG(CxT)) vs. Overexpression of CSQ alone (TG(CSQ)) and wild-type hearts was evaluated on Intracellular Ca2+ concentration peak amplitude, survival rate, cardiac fibrosis, and basal contractility. Co-overexpression of CSQ and TRN in mice normalized SR Ca2+ release compared with CSQ overexpression alone, but resulted in reduced survival, increased cardiac fibrosis, and depressed contractility.
Synapse has enriched 10 related papers. Consider them for comparative context: